SREBF1 and Hepatic steatosis: To elucidate the mechanisms involved in the progression of fatty liver diseases, we analyzed metabolically healthy C57Bl6 mice and mouse models with the fatty liver phenotype and insulin resistance, namely the alb-SREBP-1c and the aP2-SREBP-1c models.